BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15303458)

  • 1. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
    Bryowsky JJ; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
    Alos N; Eugène D; Fillion M; Powell J; Kokta V; Chabot G
    Horm Res; 2006; 65(6):289-94. PubMed ID: 16612105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
    Chatterjee M; Speiser PW
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1241-8. PubMed ID: 18183797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pamidronate in the treatment of tumor-associated hypercalcemia].
    Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
    Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for treatment of childhood hypercalcemia.
    Lteif AN; Zimmerman D
    Pediatrics; 1998 Oct; 102(4 Pt 1):990-3. PubMed ID: 9755274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition.
    Izsak EM; Shike M; Roulet M; Jeejeebhoy KN
    Gastroenterology; 1980 Sep; 79(3):555-8. PubMed ID: 6776004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia.
    Hostutler RA; Chew DJ; Jaeger JQ; Klein S; Henderson D; DiBartola SP
    J Vet Intern Med; 2005; 19(1):29-33. PubMed ID: 15715044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
    Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal symptoms, hypercalcaemia and apathetic hyperthyroidism: treatment with pamidronate.
    Ghose RR; Palmer DJ; Yaqoob M; Haboubi N; Ratcliffe WA
    Br J Clin Pract; 1994; 48(3):163-4. PubMed ID: 8031697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.